Cleared Special

Verruca-Freeze H Plus (K252903) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K252903 · Cryosurgery, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2025
Decision
29d
Days
Class 2
Risk

K252903 is an FDA 510(k) clearance for the Verruca-Freeze H Plus. Classified as Unit, Cryosurgical, Accessories (product code GEH), Class II - Special Controls.

Submitted by Cryosurgery, Inc. (Nashville, US). The FDA issued a Cleared decision on October 10, 2025 after a review of 29 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4350 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Cryosurgery, Inc. devices

Submission Details

510(k) Number K252903 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 11, 2025
Decision Date October 10, 2025
Days to Decision 29 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
86d faster than avg
Panel avg: 115d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code GEH Unit, Cryosurgical, Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4350
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEH Unit, Cryosurgical, Accessories

All 64
Devices cleared under the same product code (GEH) and FDA review panel - the closest regulatory comparables to K252903.
CryoFreeze Wart and Skin Tag Remover
K253000 · Cryosurgery, Inc. · Oct 2025
TargetCool™ (RM-DT02W)
K253114 · Recensmedical, Inc. · Oct 2025
TargetCool-e
K253348 · Recensmedical, Inc. · Oct 2025
Skin Clinic Freeze Point for Warts and Skin Tags
K251493 · Cryoconcepts LP · May 2025
Skin Clinic Nitro Clear Wart Remover
K242932 · Cryoconcepts LP · Apr 2025
CryoFreeze Wart and Skin Tag Remover
K243487 · Cryosurgery, Inc. · Mar 2025